Drug intelligence / Profile preview

Lactobacillus acidophilus La28

Development stage: Preclinical
Lead developer: Hebei Inatural Biotech
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobacillus acidophilus La28 is a specific probiotic strain developed by Hebei Inatural Biotech. As a member of the *Lactobacillus acidophilus* species, it is intended for use as a food ingredient or dietary supplement to support gastrointestinal health and maintain microbiome balance. While specific clinical indications are not detailed in the company's pipeline, *L. acidophilus* strains are generally utilized for their ability to colonize the intestinal tract, produce lactic acid, and potentially modulate the immune system or inhibit pathogenic bacteria. It is currently listed as part of Hebei Inatural Biotech's probiotic strain portfolio for various health-related applications.

Beyond the preview

Go deeper on Lactobacillus acidophilus La28.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus acidophilus La28.

Explore the full profile